Welcome to the CCO Site

Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education. 

Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.

Submit

Advances in Immunotherapy for Endometrial Cancer

Listen to Mansoor Raza Mirza, MD, and Ana Oaknin, MD, PhD, discuss the implications of recent advances in the use of immunotherapy for the treatment of patients with endometrial cancer.

This podcast is intended for clinicians practicing medicine outside of the United States.

person default
Mansoor Raza Mirza, MD
Ana Oaknin, MD, PhD
Released: November 11, 2020

In this episode, Mansoor Raza Mirza, MD, and Ana Oaknin, MD, PhD, discuss the implications of recent advances in the use of immunotherapy for the treatment of patients with endometrial cancer.

Presenters:

Ana Oaknin, MD, PhD
Head of Gynecologic Tumors Unit
Medical Oncology Department
Vall d´Hebron University Hospital
Barcelona, Spain 

Mansoor Raza Mirza, MD
Chief Oncologist
Department of Oncology,
Rigshopitalet – Copenhagen University Hospital
Copenhagen, Denmark

Acknowledgements

Supported by an educational grant from
GlaxoSmithKline

Related Content

Commentary on management challenges and incorporating novel therapies for gynecologic cancers, from Clinical Care Options (CCO)

Jubilee Brown, MD person default Elisabeth Diver, MD Released: July 5, 2022

Podcast episode with expert insights on new data from ASCO 2022 in endometrial, ovarian, and cervical cancers, from Clinical Care Options (CCO)

Jubilee Brown, MD person default Elisabeth Diver, MD Released: June 30, 2022

Downloadable clinical resource with practical guidance on how to talk with your transgender patients about gender identity, including related terminology, from Clinical Care Options (CCO)

Nelson F. Sanchez, MD
Program Director
Released: June 30, 2022

From Clinical Care Options (CCO), download slides reviewing the integration of CAR T-cell therapy into community care

Jesús G. Berdeja, MD Caron A. Jacobson, MD Released: June 30, 2022

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings